SR ONE CAPITAL MANAGEMENT, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001910264

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2024 · 11 positions · Total reported value $498.73M · Top-10 concentration 99.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 29.4% · 3 new · 0 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +35.1% · vs SPY +20.2% · Prev Value $915.44M — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2024 13F filing, SR ONE CAPITAL MANAGEMENT, LP disclosed 11 equity positions with a combined reported value of $498.73M. The filing implies a focused portfolio: its ten largest positions account for 99.5% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were ACLX ($195.97M), ZBIO ($83.10M), SPRY ($58.19M). By sector, the heaviest allocations are Health Care 60.7%, Other 39.3%. Versus the prior quarter, allocation shifted toward Health Care (+1.3pp) and away from Other (-1.3pp).

Versus the prior quarter, SR ONE CAPITAL MANAGEMENT, LP opened 3 new positions, trimmed 0 and fully exited 2, a turnover rate of 29.4% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q3 2024 were ZBIO ($83.10M), ORKA ($9.20M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • ZBIO ZENAS BIOPHARMA INC · $83.10M
  • ORKA ORUKA THERAPEUTICS INC · $9.20M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest SR ONE CAPITAL MANAGEMENT, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

SR One Capital Management is an SEC-registered 13F filer based in Redwood City, CA, United States. As of Q2 2026 it reported 15 US equity positions with a combined value of $1.04B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-119142 (status: Approved), registered 2020-07-24
  • Regulatory AUM (Form ADV): $2.44B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 19 private funds
  • Website: srone.com

Portfolio Structure

  • 15 positions · $1.04B reported value (Q2 2026)
  • Top 10 holdings = 95.1% of reported value
  • Largest position: MANE (VERADERMICS INC) at 28.4%
  • Average position size: $69.27M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 1 added, 2 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 60.7%
Other 39.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.35M $195.97M 39.29%
39.29%
Hold
2 4.91M $83.10M 16.66%
16.66%
New
3 4.01M $58.19M 11.67%
11.67%
Hold
4 1.05M $49.28M 9.88%
9.88%
Hold
5 6.53M $35.11M 7.04%
7.04%
Hold
6 2.02M $24.42M 4.90%
4.90%
Hold
7 1.96M $20.93M 4.20%
4.20%
Hold
8 3.33M $15.07M 3.02%
3.02%
Hold
9 375.33K $9.20M 1.84%
1.84%
New
10 747.75K $4.94M 0.99%
0.99%
Add
11 443.66K $2.53M 0.51%
0.51%
Hold

FAQ

What did SR ONE CAPITAL MANAGEMENT, LP buy in 2024-Q3?

In its 2024-Q3 13F filing, SR ONE CAPITAL MANAGEMENT, LP reported 11 equity positions worth $498.73M in aggregate; its largest disclosed positions were ACLX ($195.97M), ZBIO ($83.10M), SPRY ($58.19M).

How large is SR ONE CAPITAL MANAGEMENT, LP's portfolio?

SR ONE CAPITAL MANAGEMENT, LP reported $498.73M of long equity holdings across 11 positions as of 2024-Q3. Top-10 holdings account for 99.5% of reported value.

What is SR ONE CAPITAL MANAGEMENT, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sr-one-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →